Quality improvement project to reduce perioperative opioid oversedation events in a paediatric hospital.

Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention's 2016 opioid guideline.

Bohnert ASB, Guy GP Jr, Losby JL. Ann Intern Med. 2018;169:367-375.

Association of hydrocodone schedule change with opioid prescriptions following surgery.

Habbouche J, Lee J, Steiger R, et al. JAMA Surg. 2018 Aug 22; [Epub ahead of print].

Association of the use of a mandatory prescription drug monitoring program with prescribing practices for patients undergoing elective surgery.

Stucke RS, Kelly JL, Mathis KA, Hill MV, Barth RJ. JAMA Surg. 2018 Aug 22; [Epub ahead of print].

Parenteral opioid shortage—treating pain during the opioid-overdose epidemic.

Bruera E. N Engl J Med. 2018;379:601-603.

Interventions for postsurgical opioid prescribing: a systematic review.

Wetzel M, Hockenberry J, Raval MV. JAMA Surg. 2018;153:948-954.

NAM Action Collaborative on Countering the U.S. Opioid Epidemic.

Washington DC: National Academy of Medicine and the Aspen Institute.

AHRQ Announces Interest in Health Services Research to Address the Opioids Crisis.

Rockville, MD: Agency for Healthcare Research and Quality. Special Emphasis Notice. August 2, 2018. Publication No. NOT-HS-18-015.

Trends in opioid use in commercially insured and Medicare Advantage populations in 2007–16: retrospective cohort study.

Jeffery MM, Hooten WM, Henk HJ, et al. BMJ. 2018;362:k2833.

Outpatient opioid prescriptions for children and opioid-related adverse events.

Chung CP, Callahan ST, Cooper WO, et al. Pediatrics. 2018;142:e20172156.

"The Ultrasound Looked Fine": Point-of-Care Ultrasound and Patient Safety

Resa E. Lewiss, MD

Six Building Blocks: A Team-Based Approach to Improving Opioid Management in Primary Care.

MacColl Center for Health Care Innovation at the Kaiser Permanente of Washington Research Institute; University of Washington.

Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study.

Larochelle MR, Bernson D, Land T, et al. Ann Intern Med. 2018;169:137-145.

Potentially inappropriate opioid prescribing, overdose, and mortality in Massachusetts, 2011–2015.

Rose AJ, Bernson D, Chui KKH, et al. J Gen Intern Med. 2018;33:1512-1519.

Opioid prescribing decreases after learning of a patient's fatal overdose.

Doctor JM, Nguyen A, Lev R, et al. Science. 2018;361:588-590.

Four states with robust prescription drug monitoring programs reduced opioid dosages.

Haffajee RL, Mello MM, Zhang F, Zaslavsky AM, Larochelle MR, Wharam JF. Health Aff (Millwood). 2018;37:964-974.

The burden of opioid-related mortality in the United States.

Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. JAMA Network Open. 2018;1:e180217.

Labeling morphine milligram equivalents on opioid packaging: a potential patient safety intervention.

Stone AB, Urman RD, Kaye AD, Grant MC. Curr Pain Headache Rep. 2018;22:46.

Progress Made Towards Improving Opioid Safety, But Further Efforts to Assess Progress and Reduce Risk Are Needed.

Washington, DC: United States Government Accountability Office; May 2018. Publication GAO-18-380.

Association of opioid-related adverse drug events with clinical and cost outcomes among surgical patients in a large integrated health care delivery system.

Shafi S, Collinsworth AW, Copeland LA, et al. JAMA Surg. 2018;153:757-763.

Patterns of potential opioid misuse and subsequent adverse outcomes in Medicare, 2008 to 2012.

Carey CM, Jena AB, Barnett ML. Ann Intern Med. 2018;168:837-845.